Exagen Inc.XGNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR-14.1%
5Y CAGR+11.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-14.1%/yr
vs +46.8%/yr prior
5Y CAGR
+11.9%/yr
Recent deceleration
Acceleration
-61.0pp
Decelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $6.25M | +16.4% |
| 2024 | $5.38M | +10.5% |
| 2023 | $4.87M | -50.7% |
| 2022 | $9.88M | +36.5% |
| 2021 | $7.24M | +102.8% |
| 2020 | $3.57M | +64.0% |
| 2019 | $2.18M | +2.4% |
| 2018 | $2.13M | +37.0% |
| 2017 | $1.55M | +13.5% |
| 2015 | $1.37M | - |